BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Foghorn Therapeutics

Foghorn Therapeutics  logo

United States of America based
$50 M

Foghorn Therapeutics is developing therapies based on a system that directs which genes our cells express, and when, where, and in what order.By manipulating this system with our unique Gene Traffic ControlTM platform, Foghorn will change how genes turn “on” and “off.” Unlike approaches that edit genes, this novel way of thinking will alter what our DNA has in store for us—and rewrite destiny for millions of people living with disease.With Gene Traffic ControlTM Foghorn is pioneering a new, major class of drug targets to develop unprecedented therapies for cancer and other serious diseases. We have already validated multiple targets, are in the process of developing drug candidates in multiple types of cancer and are beginning to explore other diseases.


Epigenetics Startups  

R&D Platform


No pipelines published yet




No services posted yet